Jeff Smith, Starboard Value CEO, joins CNBC's 'Squawk on the Street' to discuss how he sees Pfizer going forward, potential ...

Activist investor Starboard Value reportedly has taken a large stake in consumer health products maker Kenvue.

Adds Kenvue comment. Kenvue (NYSE:KVUE) needs to focus on fixing its skin, health and beauty segments, Jeff Smith, founder ...

Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...

Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has ...

Starboard Value has a sizable stake in Kenvue (KVUE) and wants the company to make changes to boost its share price, Lauren Thomas of Wall ...

Financial writer reports activist investor Starboard Value's stake in Kenvue Inc., seeking measures to boost stock price.

Starboard Value contends that Kenvue, with strong consumer health brands like Tylenol and Listerine, is underperforming its ...

Starboard Value, an activist investor, has reportedly acquired a substantial stake in Kenvue Inc, the company behind popular ...

Activist investor Starboard Value reportedly has taken a large stake in consumer health care products maker Kenvue. Starboard founder and CEO Jeff Smith is expected to discuss the hedge fund's ...

The Journal noted that Starboard founder and Chief Executive Officer (CEO) Jeff Smith is expected to outline the firm's plans for Kenvue at tomorrow's 13D Monitor Active-Passive Investor Summit in ...